The telecom giant's latest results highlighted impressive growth and strong guidance, further securing its robust dividend.

If Novo Nordisk's initiatives work and the company can cut the cost and time to develop drugs by even 5%, that could have a ...

Some stocks saw massive surges during the early pandemic years because their businesses were well-positioned to perform well ...

Stefon Walters is a contributing Motley Fool stock market analyst covering publicly traded companies across technology, consumer goods, and financials, as well as retirement planning. Stefon is a ...

Amazon generates higher revenue and profits. Yet it also generally grows its top line faster than Costco. And on top of that, ...

After falling into bear market territory, Nvidia stock has come roaring back, climbing to a new all-time high. The ongoing ...

Three sectors that could be the most at risk for share-price disruption are cybersecurity, banking, and cryptocurrency stocks. And among these sectors, a handful of companies could potentially feel ...

These three healthcare giants have dealt with slow revenue growth in recent years. All three have continued to increase their ...

Poet's dramatic valuation pullback today came despite a relatively calm backdrop for the broader market. The S&P 500's level ...

Eli Lilly is best known for its work in the weight loss market. The company has billion-dollar drugs in other areas. The ...

Nokia rose after an analyst upgrade pointed to stronger demand in optical transport and IP routing, with data center ...

One of the livelier biotech stocks on the market Monday was Celcuity (CELC +3.84%), which saw its share price leap nearly 4% ...